CA Patent

CA2381425A1 — Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties

Assigned to CellGate Inc · Expires 2001-03-01 · 25y expired

What this patent protects

This invention provides compositions and methods for enhancing delivery of drugs and other agents across epithelial tissues, including the skin, gastrointestinal tract, pulmonary epithelium, and the like. The compositions and methods are also useful for delivery across endotheli…

USPTO Abstract

This invention provides compositions and methods for enhancing delivery of drugs and other agents across epithelial tissues, including the skin, gastrointestinal tract, pulmonary epithelium, and the like. The compositions and methods are also useful for delivery across endothelial tissues, includi ng the blood brain barrier. The compositions and methods employ a delivery enhancing transport that has sufficient guanidino or amidino sidechain moieties to enhance delivery of a compound conjugated to the reagent across one or more layers of the tissue, compared to the non-conjugated compound. T he delivery enhancing polymers include, for example, poly-arginine molecules th at are preferably between about 6 and 25 residues in length.

Drugs covered by this patent

Patent Metadata

Patent number
CA2381425A1
Jurisdiction
CA
Classification
Expires
2001-03-01
Drug substance claim
No
Drug product claim
No
Assignee
CellGate Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.